Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on June 21, 2004

Circulation. 2004
Published online before print June 21, 2004, doi: 10.1161/01.CIR.0000133384.38551.A8
A more recent version of this article appeared on July 6, 2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/1/91    most recent
01.CIR.0000133384.38551.A8v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kouroedov, A.
Right arrow Articles by Cosentino, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kouroedov, A.
Right arrow Articles by Cosentino, F.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Other diabetes
Right arrow Other Vascular biology

Submitted on December 11, 2003
Revised on March 30, 2004
Accepted on April 2, 2004

Selective Inhibition of Protein Kinase C{beta}2 Prevents Acute Effects of High Glucose on Vascular Cell Adhesion Molecule-1 Expression in Human Endothelial Cells

Alexei Kouroedov MD, Masato Eto MD, PhD, Hana Joch , Massimo Volpe MD, Thomas F. Lüscher MD, and Francesco Cosentino MD, PhD*

From Cardiovascular Research, Institute of Physiology, University of Zürich and Cardiovascular Center, University Hospital, Zürich, Switzerland (A.K., M.E., H.J., T.F.L., F.C.); and the Division of Cardiology, 2nd Faculty of Medicine, University La Sapienza, Rome, and IRCCS Neuromed, Pozzilli, Italy (M.V., F.C.).

* To whom correspondence should be addressed. E-mail: f_cosentino{at}hotmail.com.

Background--Enhanced expression of adhesion molecules by the endothelium may account for vascular damage in diabetics and nondiabetic patients who develop stress hyperglycemia during acute myocardial infarction. We analyzed the phosphorylation of protein kinase C{beta}2 (PKC{beta}2) at serine/threonine residues, which may contribute to the endothelial dysfunction during acute hyperglycemia. Furthermore, this study was designed to investigate whether selective blockade of this regulatory mechanism may prevent the development of endothelial hyperadhesiveness.

Methods and Results--Incubation of the human aortic endothelial cells with high glucose (22.2 mmol/L) resulted in significant increase of vascular cell adhesion molecule (VCAM)-1 protein expression (172±15% versus control; P<0.01). Phorbol 12-myristate 13-acetate, a potent activator of PKC, mimicked the effect of high glucose on VCAM-1 expression. High glucose led to a rapid increase (181±22% versus control; P<0.01) of membrane-bound PKC{beta}, reflecting activation of this enzyme. The nonselective inhibitor of PKC{beta}1 and PKC{beta}2 isoforms LY379196, as well as CGP53353, a highly selective inhibitor of PKC{beta}2, prevented in a dose-dependent manner upregulation of VCAM-1. Incubation with high glucose was associated with increased PKC{beta}2 phosphorylation at the Ser-660 residue, and both LY379196 and CGP53353 prevented this event. Exposure of the cells to high glucose also reduced the protein level of the inhibitory subunit of nuclear factor-{kappa}B, I{kappa}B{alpha}, leading to its enhanced binding activity. Selective inhibition of PKC{beta} abolished I{kappa}B{alpha} degradation.

Conclusions--Our findings demonstrate for the first time that phosphorylation of Ser-660 represents a selective regulatory mechanism for glucose-induced upregulation of VCAM-1. Therefore, PKC{beta}2-selective inhibitors may be promising drugs for treatment of endothelial dysfunction during acute hyperglycemia and possibly in diabetes.


Key words: diabetes mellitus • cell adhesion molecules • endothelium • inhibitors




This article has been cited by other articles:


Home page
StrokeHome page
F. Cosentino, R. Battista, A. Scuteri, F. De Sensi, L. De Siati, C. Di Russo, G. G. Camici, and M. Volpe
Impact of Fasting Glycemia and Regional Cerebral Perfusion in Diabetic Subjects: A Study With Technetium-99m-Ethyl Cysteinate Dimer Single Photon Emission Computed Tomography
Stroke, January 1, 2009; 40(1): 306 - 308.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Osto, A. Kouroedov, P. Mocharla, A. Akhmedov, C. Besler, L. Rohrer, A. von Eckardstein, S. Iliceto, M. Volpe, T. F. Luscher, et al.
Inhibition of Protein Kinase C{beta} Prevents Foam Cell Formation by Reducing Scavenger Receptor A Expression in Human Macrophages
Circulation, November 18, 2008; 118(21): 2174 - 2182.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
T. F. Luscher and J. Steffel
Sweet and Sour: Unraveling Diabetic Vascular Disease
Circ. Res., January 4, 2008; 102(1): 9 - 11.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. A. Borger, P. M. Murphy, A. Alam, S. Fazel, M. Maganti, S. Armstrong, V. Rao, and T. E. David
Initial results of the chordal-cutting operation for ischemic mitral regurgitation
J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1483 - 1492.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Fukuoka, M. Nonaka, S. Masuyama, T. Shimamoto, K. Tambara, H. Yoshida, T. Ikeda, and M. Komeda
Chordal "translocation" for functional mitral regurgitation with severe valve tenting: An effort to preserve left ventricular structure and function
J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1004 - 1011.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. E. Kanter, F. Johansson, R. C. LeBoeuf, and K. E. Bornfeldt
Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques?
Circ. Res., March 30, 2007; 100(6): 769 - 781.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Kawakami, M. Aikawa, P. Alcaide, F. W. Luscinskas, P. Libby, and F. M. Sacks
Apolipoprotein CIII Induces Expression of Vascular Cell Adhesion Molecule-1 in Vascular Endothelial Cells and Increases Adhesion of Monocytic Cells
Circulation, August 15, 2006; 114(7): 681 - 687.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Gao, F. Wang, B. Wang, B. Gong, J. Zhang, X. Zhang, and J. Zhao
Cilostazol Protects Diabetic Rats from Vascular Inflammation via Nuclear Factor-{kappa}B-Dependent Down-Regulation of Vascular Cell Adhesion Molecule-1 Expression
J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 53 - 58.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Vecchione, A. Aretini, G. Marino, U. Bettarini, R. Poulet, A. Maffei, M. Sbroggio, L. Pastore, M. T. Gentile, A. Notte, et al.
Selective Rac-1 Inhibition Protects From Diabetes-Induced Vascular Injury
Circ. Res., February 3, 2006; 98(2): 218 - 225.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. De Caterina, A. Zampolli, S. Del Turco, R. Madonna, and M. Massaro
Nutritional mechanisms that influence cardiovascular disease
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 421S - 426S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S.-Q. Wu and W. C. Aird
Thrombin, TNF-{alpha}, and LPS exert overlapping but nonidentical effects on gene expression in endothelial cells and vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H873 - H885.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Rikitake and J. K. Liao
Rho-Kinase Mediates Hyperglycemia-Induced Plasminogen Activator Inhibitor-1 Expression in Vascular Endothelial Cells
Circulation, June 21, 2005; 111(24): 3261 - 3268.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
C. Rask-Madsen and G. L. King
Proatherosclerotic Mechanisms Involving Protein Kinase C in Diabetes and Insulin Resistance
Arterioscler Thromb Vasc Biol, March 1, 2005; 25(3): 487 - 496.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. He and G. L. King
Protein Kinase C{beta} Isoform Inhibitors: A New Treatment for Diabetic Cardiovascular Diseases
Circulation, July 6, 2004; 110(1): 7 - 9.
[Full Text] [PDF]